Skip to main content
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Cancer, Clearly
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Online First
Special Issues
Categories
Anemia Resources
HOPA Corner
Web Exclusives
All Web Exclusives
Cancer, Clearly
Emerging Data and Trends in HR-Positive/HER2-Negative Breast Cancer
Did You Know? Beyond the Data
Case-Based Exchanges
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ESMO 2025 - Early Breast Cancer
ASCO 2025 - Breast Cancer Faculty Commentary
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Biosimilar Resources
Managing Adverse Events in Patients Utilizing Antibody-Drug Conjugate Therapy
Voices From ASCO 2025
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Quick Quiz
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor/Perspectives
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
Editorial Board
Editorial Process
Advertising Policy
Advertise
Original Research
The Risk of Neurotoxicity with Concomitant Use of Aprepitant and Ifosfamide
Anthony Jarkowski III, PharmD, BCOP
,
Austin Miller, PhD
,
Tammy A. Hecke, RN, BSN
,
Leona Blustein, PharmD
,
Michael K.K. Wong, MD, PhD, FRCPC
Read More
Practical Issues in Pharmacy Management
Implementation of a Pharmacist-Managed Interdisciplinary Oral Chemotherapy Program in a Community Cancer Center
Robert Mancini, PharmD, BCOP, FHOPA
,
Lindsay M. Kaster, PharmD
,
Brian Vu, PharmD
,
Jessie Modlin, PharmD
,
David B. Wilson, RPh
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Online First
Exemestane: A Promising New Option for Primary Prevention of Breast Cancer
Audrey Andrews
Read More
Online First
Bevacizumab in Ovarian Cancer: More Support for Maintenance
Audrey Andrews
Read More
Online First
Novel Agents Improve Survival in Metastatic Melanoma
Audrey Andrews
Read More
Online First
PARP Inhibitor Prolongs Progression-Free Survival in Ovarian Cancer
Audrey Andrews
Read More
Online First
Supportive Care
NCCN Helps Guide Optimal Use of Myeloid Growth Factors for Prevention of Neutropenia
Audrey Andrews
Read More
Online First
Novel Prostate Brachytherapy Technique May Reduce Posttreatment Urinary Complications
John Schieszer
Read More
Online First
For Palliation of Severe Dysphagia, Small-Caliber Stents Work Well With Fewer Complications
Caroline Helwick
Read More
190
191
192
193
194
195
196
Page 193 of 198
Results 1921 - 1930 of 1975
